Progenics Pharmaceuticals
Why Robinhood?
You can watch PGNX and buy or sell other stocks, ETFs, and their options commission-free!About PGNX
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology.
PGNX Key Statistics
Stock Snapshot
As of today, Progenics Pharmaceuticals(PGNX) shares are valued at $4.10. The company's market cap stands at 355.05M, with a P/E ratio of -5.30.
On 2026-07-23, Progenics Pharmaceuticals(PGNX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Progenics Pharmaceuticals(PGNX) stock has reached 0, versus its average volume of 4.5M.
The stock's 52-week range extends from a low of $1.89 to a high of $6.37.
The stock's 52-week range extends from a low of $1.89 to a high of $6.37.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.